Aquestive Therapeutics Inc (AQST)

Apr 03, 2025

New Jersey Pharma Co. Shares Positive Pediatric Study - streetwisereports.com

Apr 03, 2025

Apr 03, 2025

Aquestive completes marketing application for Anaphylm in U.S. - MSN

Apr 03, 2025

Apr 01, 2025

Aquestive stock gains as Anaphylm NDA completes (AQST:NASDAQ) - Seeking Alpha

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics Concludes FDA Application For Allergy Drug With Encouraging Pediatric Trial Data - Benzinga

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics’ Anaphylm NDA Submission and Strong Clinical Profile Support Buy Rating - TipRanks

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film - BioSpace

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics Awaits FDA Decision on Anaphylm NDA - TipRanks

Apr 01, 2025

Apr 01, 2025

Aquestive’s Anaphylm shows promise in pediatric study - Investing.com

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics Announces Positive Topline PK - GlobeNewswire

Apr 01, 2025

Apr 01, 2025

Revolutionary Allergy Treatment Proves Safe in Children: Game-Changing Alternative to EpiPen Heads to FDA - Stock Titan

Apr 01, 2025

Apr 01, 2025

Charles Schwab Investment Management Inc. Grows Stock Holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Apr 01, 2025

Mar 31, 2025

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Rating of “Buy” from Analysts - Defense World

Mar 31, 2025

Mar 30, 2025

Aquestive stock falls amid Libervant approval, Anaphylm update - MSN

Mar 30, 2025

Mar 27, 2025

Bank of New York Mellon Corp Reduces Stock Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Mar 27, 2025

Mar 25, 2025

Aquestive Therapeutics: Oral Anaphylaxis NDA Opportunity Spells Buy - Seeking Alpha

Mar 25, 2025

Mar 24, 2025

Aquestive Therapeutics: Not For Me, But Attractive (NASDAQ:AQST) - Seeking Alpha

Mar 24, 2025

Mar 21, 2025

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) P/S Is On The Mark - simplywall.st

Mar 21, 2025

Mar 13, 2025

What is HC Wainwright’s Estimate for AQST Q1 Earnings? - Defense World

Mar 13, 2025

Mar 12, 2025

What is HC Wainwright’s Forecast for AQST FY2026 Earnings? - Defense World

Mar 12, 2025

Mar 11, 2025

Aquestive Therapeutics (NASDAQ:AQST) Given Buy Rating at HC Wainwright - Defense World

Mar 11, 2025

Mar 10, 2025

Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks

Mar 10, 2025

Mar 10, 2025

Aquestive Therapeutics Advances Product Pipeline and Market Access - TipRanks

Mar 10, 2025

Mar 10, 2025

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 10, 2025

Mar 10, 2025

Buy Rating on Aquestive Therapeutics Driven by Anaphylm’s Regulatory Progress and Strategic Launch Preparations - TipRanks

Mar 10, 2025

Mar 09, 2025

Aquestive Therapeutics Stock Dips After-Hours On Q4 Miss — Retail Eyes Silver Linings - MSN

Mar 09, 2025

Mar 09, 2025

Lake Street Capital Lowers Aquestive Therapeutics (NASDAQ:AQST) Price Target to $8.00 - Defense World

Mar 09, 2025

Mar 08, 2025

Earnings Update: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance

Mar 08, 2025

Mar 07, 2025

Aquestive Therapeutics price target lowered to $4.75 from $5.50 at Alliance Global Partners - TipRanks

Mar 07, 2025

Mar 07, 2025

New York State Common Retirement Fund Grows Stock Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Mar 07, 2025

Mar 06, 2025

Aquestive Therapeutics Reports 2024 Financial Results and Strategic Progress - TipRanks

Mar 06, 2025

Mar 06, 2025

Aquestive Therapeutics: Strategic Advancements and Financial Strength Underpin Buy Rating - TipRanks

Mar 06, 2025

Mar 06, 2025

Earnings call transcript: Aquestive Therapeutics Q4 2024 misses estimates By Investing.com - Investing.com UK

Mar 06, 2025

Mar 06, 2025

Earnings call transcript: Aquestive Therapeutics Q4 2024 misses estimates - Investing.com

Mar 06, 2025

Mar 06, 2025

Aquestive Therapeutics: Q4 Earnings Snapshot - Midland Daily News

Mar 06, 2025

Mar 06, 2025

Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 06, 2025

Mar 06, 2025

Aquestive Therapeutics Q4 Net Loss Widens, Revenue Falls; 2025 Revenue Outlook Issued - Marketscreener.com

Mar 06, 2025

Mar 06, 2025

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Mar 06, 2025

Mar 05, 2025

Aquestive Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 05, 2025

Mar 05, 2025

Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 05, 2025

Mar 05, 2025

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics - Nasdaq

Mar 05, 2025

Mar 05, 2025

Aquestive Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 05, 2025

Mar 05, 2025

Aquestive Therapeutics reports Q4 EPS (19c), consensus (13c) - TipRanks

Mar 05, 2025

Mar 05, 2025

Aquestive Therapeutics misses Q4 estimates, shares fall By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

Aquestive Therapeutics misses Q4 estimates, shares fall - Investing.com India

Mar 05, 2025